0000000000321257

AUTHOR

Guillaume Serzian

showing 3 related works from this author

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treate…

2021

Background We assessed the impact of preprocedural plasma levels of MRproANP (midregional N‐terminal pro–atrial natriuretic peptide) and sST2 (soluble suppression of tumorigenicity 2) on recurrence of atrial fibrillation (AF) at 1 year after catheter ablation of AF. Methods and Results This was a prospective, multicenter, observational study including patients undergoing catheter ablation of AF. MRproANP and sST2 were measured in a peripheral venous blood preprocedure, and MRproANP was assessed in the right and left atrial blood during ablation. The primary end point was recurrent AF between 3 and 12 months postablation, defined as a documented (>30 seconds) episode of AF, flutter, or a…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_classmedicine.medical_treatmentBiorhythmCatheter ablation030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineHeart RatePredictive Value of TestsRecurrenceRisk FactorsInternal medicinecatheter ablationAtrial FibrillationmedicineNatriuretic peptideHumansIn patientArrhythmia and Electrophysiology030212 general & internal medicineHeart AtriaProspective StudiesOriginal ResearchAgedsST2business.industryMRproANPbiomarkersAtrial fibrillationPlasma levelsMiddle Agedmedicine.diseaseInterleukin-1 Receptor-Like 1 ProteinUp-RegulationHeart RhythmTreatment OutcomePro atrial natriuretic peptideCardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessCatheter Ablation and Implantable Cardioverter-DefibrillatorAtrial Natriuretic FactorJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
researchProduct

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis

2021

Abstract Aims Cardiac resynchronization therapy (CRT) is highly effective in dilated cardiomyopathy (DCM) patients with impaired left ventricular ejection fraction (LVEF) and left bundle block branch. In cardiac amyloidosis (CA) patients, left ventricular dysfunction and conduction defects are common, but the potential of CRT to improve cardiac remodelling and survival in this particular setting remains undefined. We investigated cardiovascular outcomes in CA patients after CRT implantation in terms of CRT echocardiographic response and major cardiovascular events (MACEs). Methods and results Our retrospective study included 47 CA patients implanted with CRT devices from January 2012 to Feb…

medicine.medical_specialtygenetic structuresmedicine.medical_treatmentPopulationCardiac resynchronization therapyHeart failureCardiac amyloidosisVentricular Function LeftInternal medicineImplantable cardioverter defibrillatormedicineHumansDiseases of the circulatory (Cardiovascular) systemcardiovascular diseaseseducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studyCardiac resynchronization therapyEjection fractionbusiness.industryHazard ratioDilated cardiomyopathyStroke VolumeOriginal ArticlesAmyloidosismedicine.diseaseImplantable cardioverter-defibrillatorDefibrillators ImplantablePacemakerTreatment OutcomeCardiac amyloidosisHeart failureRC666-701Cardiologycardiovascular systemOriginal ArticleCardiology and Cardiovascular Medicinebusinesstherapeuticscirculatory and respiratory physiologyESC Heart Failure
researchProduct

Impact of early (<7 days) pacemaker implantation after cardiac surgery on long‐term pacemaker dependency

2021

We aimed to investigate pacemaker dependency after at least 1 year in patients with early (7 days) implantation, compared to those who received a pacemaker ≥7 days after cardiac surgery. Secondary endpoints were length of hospital stay and in-hospital complications.Retrospective analysis of 108 consecutive patients who received a pacemaker after cardiac surgery between 06/2012 and 06/2018. Characteristics and outcomes were compared between patients with early (7 days) and late (≥7 days) implantation. Patients were followed up with evaluation of pacemaker dependency between April and June 2019. We identified predictors of dependency by logistic regression.In total, 63.9% were men, average ag…

MalePacemaker Artificialmedicine.medical_specialty030204 cardiovascular system & hematologyPacemaker implantationlaw.invention03 medical and health sciencesPostoperative Complications0302 clinical medicineRandomized controlled trialRisk FactorslawInternal medicinemedicineHumansIn patient030212 general & internal medicineCardiac Surgical ProceduresAgedRetrospective Studiesbusiness.industryGeneral MedicineLength of StayPacemaker dependencyCardiac surgeryCardiologyFemaleFrancePermanent pacemakerCardiology and Cardiovascular MedicinebusinessPacing and Clinical Electrophysiology
researchProduct